PT - JOURNAL ARTICLE AU - Hunziker, Patrick TI - Minimizing exposure to respiratory droplets, ‘jet riders’ and aerosols in air-conditioned hospital rooms by a ‘Shield-and-Sink’ strategy AID - 10.1101/2020.12.08.20233056 DP - 2020 Jan 01 TA - medRxiv PG - 2020.12.08.20233056 4099 - http://medrxiv.org/content/early/2020/12/16/2020.12.08.20233056.short 4100 - http://medrxiv.org/content/early/2020/12/16/2020.12.08.20233056.full AB - Objectives In COVID-19, transfer of respiratory materials transmits disease but the interplay of droplet and aerosol physics, physiology and environment is not fully understood. To advance understanding of disease transmission mechanisms and to find novel exposure minimization strategies, we studied cough-driven material transport modes and the efficacy of control strategies.Design and methods Computer simulations and real-world experiments were used for integrating an intensive care setting, multi- physics, and physiology. Patient-focused airflow management and air purification strategies were examined computationally and validated by submicron particle exhalation imaging in volunteers.Results Respiratory materials ejected by cough exhibited four transport modes: long-distance ballistic, short- distance ballistic, “jet rider”, and aerosol modes. Interaction with air conditioning driven flow contaminated a hospital room rapidly. Different than large droplets or aerosols, “jet rider” droplets travelled with the turbulent air jet initially, but fell out at a distance, were not well eliminated by air conditioning and exposed bystanders at larger distance and longer time; their size predisposes them to preferential capture in the nasal mucosa, the primordial COVID-19 infection site. “Cough shields” captured large droplets but induced lateral dispersion of aerosols and jet riders. An air purification device alone had limited efficacy. A “Shield and Sink” approach combining “cough shields” with “virus sinks” miminized exposure to all secretions in modeling and real-life experiments.Conclusions “Jet riders” have characteristics of highly efficient respiratory infection vectors and may play a role in Covid- 19 transmission. Exposure to all droplet types can be minimized through an easily implemented “Shield and Sink” strategy.Graphical abstractCough-triggered dispersion of respiratory secretions of different sizes in a hospital room with air conditioning, and effective source control against dispersion by «Shield & Sink» strategy.Article Summary – strengths and limitations- The novel “Shield and Sink” approach for source control of droplets, “jet riders” and aerosols emitted by coughing patients permits significant reduction of the transfer of such potentially infectious materials in a hospital setting.- As a rapidly and inexpensively implementable infrastructural measure, it has the potential of contributing to mitigation and control of the Covid-19 pandemic.- The study is performed in a hospital setting and the Covid-19 pandemic, but the implications and principles of “Shield and Sink” air management for respiratory disease transmission control are generalizable to other settings and infectious agents.Competing Interest StatementThe authors have declared no competing interest.Funding Statementown fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was submitted to the responsible Ethics Commission Northwest and Central Switzerland EKNZ (Req-2020-01362) that ruled that the study is not categorized as clinical study and does not require Ethical Committee permission. The persons visualized in figures and supplements gave written informed consent for participation and consented to their images and videos being published for scientific purposes.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data are available on request from the author for scientific purposes with suited attribution and as long as the manuscript is not published, an agreement on confidentiality.